A Pharmacists’ Defence Association (PDA) survey on working conditions across the sector was used by the Guardian as part of its allegations that target pressures are affecting patient safety at the multiples.
One month after the article was published, PDA chair Mark Koziol tells C+D what the organisation has been working on since.
C+D will releasing its full interview with Mr Koziol as a podcast later this month.
Find out what C+D learned from the PDA’s safety survey here, and read one anonymous pharmacist’s stories of target pressures here.
What action would you like to see the PDA take next?
We want to hear your views, but please express them in the spirit of a constructive, professional debate. For more information about what this means, please click here to see our community principles and information
The views and opinions discussed during this video news blog represent those of the speakers and not of Actavis UK Ltd Actavis
Reporting forms and information can be found at http://www.mhra.gov.uk/yellowcard
Adverse events can also be reported to Actavis on 01271 385257
* ‘Patient safety is Actavis’ primary concern and we encourage healthcare professionals and patients to report any adverse event which may occur in relation to an Actavis product. An adverse event includes reports of any side effect, product misuse, abuse or overdose, including inappropriate use by children or women who are pregnant or breast-feeding. It also includes reports of a product that was used for something other than the intended purpose or was ineffective, or was given with another medicine. Complaints relating to the product can also be reported.’